Ensuring Patient Access to Substance Use Disorder Treatments Act of 2018

Summary

Ensuring Patient Access to Substance Use Disorder Treatments Act of 2018 This bill amends the Controlled Substances Act to allow a pharmacy to deliver a controlled substance to a practitioner, in accordance with a prescription, to be administered to a specific patient for maintenance or detoxification treatment or through an intrathecal pump. The bill directs the Government Accountability Office to report to Congress on access to and the potential diversion of controlled substances administered by injection, implantation, or through the use of an intrathecal pump.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

1. 7 March 2018

   Introduced

   Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

   Source: IntroReferral

2. 7 March 2018

   Introduced

   Introduced in House

   Source: IntroReferral

3. 7 March 2018

   Introduced

   Introduced in House

   Source: IntroReferral

4. 9 March 2018

   Referred

   Referred to the Subcommittee on Health.

   Source: Committee

5. 6 April 2018

   Referred

   Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations.

   Source: Committee

6. 25 April 2018

   Committee

   Forwarded by Subcommittee to Full Committee by Voice Vote .

   Source: Committee

7. 25 April 2018

   Committee

   Subcommittee Consideration and Mark-up Session Held.

   Source: Committee

8. 9 May 2018

   Reported

   Ordered to be Reported by Voice Vote.

   Source: Committee

9. 9 May 2018

   Committee

   Committee Consideration and Mark-up Session Held.

   Source: Committee

Votes

No vote records are attached yet.

Versions

• Introduced in House · 7 March 2018 · Download file

Documents

3 official files

• Introduced in House (text)

  Introduced in House · EN · 7 March 2018

  ViewDownloadOpen at official source

• Introduced in House (PDF)

  Introduced in House · EN · 7 March 2018

  ViewDownloadOpen at official source

  Leesvertaling

  Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

  Vertaal naarNL · DutchDE · GermanFR · FrenchES · SpanishIT · ItalianPL · PolishPT · PortugueseSV · SwedishDA · DanishFI · FinnishEL · GreekCS · CzechHU · HungarianRO · RomanianBG · BulgarianHR · CroatianSK · SlovakSL · SlovenianLT · LithuanianLV · LatvianET · EstonianGA · IrishMT · Maltese

  Vertaal document

  Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

• Introduced in House

  summary · EN · 7 March 2018

  Open at official source

  Leesvertaling

  Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

  Vertaal naarNL · DutchDE · GermanFR · FrenchES · SpanishIT · ItalianPL · PolishPT · PortugueseSV · SwedishDA · DanishFI · FinnishEL · GreekCS · CzechHU · HungarianRO · RomanianBG · BulgarianHR · CroatianSK · SlovakSL · SlovenianLT · LithuanianLV · LatvianET · EstonianGA · IrishMT · Maltese

  Vertaal document

  Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

Sponsors

• Rep. Costello, Ryan A. [R-PA-6] · R · Sponsor
• Rep. Nolan, Richard M. [D-MN-8] · D · Sponsor
• Rep. Stefanik, Elise M. [R-NY-21] · R · Cosponsor
• Karen Handel · R · Cosponsor
• Rep. Rouzer, David [R-NC-7] · R · Cosponsor
• Sen. Blackburn, Marsha [R-TN] · R · Cosponsor
• Rep. Walden, Greg [R-OR-2] · R · Cosponsor
• Rep. Tenney, Claudia [R-NY-24] · R · Cosponsor
• · hsif00 · Standing
• · hsju00 · Standing

Related records

• related to → Ensuring Patient Access to Substance Use Disorder Treatments Act of 2018
• related to ← Opioid Crisis Response Act of 2018